Clinical Trials

Showing trials with last updates posted in 2021.

NCT00381940 | COMPLETED | PHASE2
26 participants

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2021-03-24
Start Date:
2007-01-31
Completion:
2008-06-30
Conditions
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • Adult Lymphocyte Predominant Hodgkin Lymphoma
  • Adult Mixed Cellularity Hodgkin Lymphoma
  • Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Adult Nodular Sclerosis Hodgkin Lymphoma
  • Childhood Lymphocyte Depletion Hodgkin Lymphoma
  • Childhood Lymphocyte Predominant Hodgkin Lymphoma
  • Childhood Mixed Cellularity Hodgkin Lymphoma
  • Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Childhood Nodular Sclerosis Hodgkin Lymphoma
  • Recurrent Adult Hodgkin Lymphoma
  • Recurrent/Refractory Childhood Hodgkin Lymphoma
  • Stage I Adult Hodgkin Lymphoma
  • Stage I Childhood Hodgkin Lymphoma
  • Stage II Adult Hodgkin Lymphoma
  • Stage II Childhood Hodgkin Lymphoma
  • Stage III Adult Hodgkin Lymphoma
  • Stage III Childhood Hodgkin Lymphoma
  • Stage IV Adult Hodgkin Lymphoma
  • Stage IV Childhood Hodgkin Lymphoma
Interventions
  • DRUG
  • BIOLOGICAL
NCT04811222 | UNKNOWN | NA
55 participants

DOTATATE PETMRI AAA Study

Study Type:
INTERVENTIONAL
Last Updated:
2021-03-23
Start Date:
2021-02-15
Completion:
2023-12-31
Conditions
  • Abdominal Aortic Aneurysm
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page